Shu Ran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shu Ran has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Baolin Liu
School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China
14 shared publicationsBao-Lin Liu
School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China
5 shared publications- Hong-Wen Deng
School of Medicine, Tulane University, New Orleans, USA
4 shared publications BaoLin Liu
School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, People’s Republic of China
3 shared publicationsMin-Fei Zhao
School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China
3 shared publicationsQing Tian
Department of Biostatistics, Tulane University, New Orleans, Louisiana, USA
3 shared publications
Latest Publications
- 15 September 2026
- Published by Elsevier in Journal of Thermal Biology
- Vol. 141
Multi-omics integration and colocalization analyses prioritize candidate molecular loci associated with hypothermia
- 15 September 2026
- Published by Elsevier in Journal of Thermal Biology
- Vol. 141
Multi-omics integration and colocalization analyses prioritize candidate molecular loci associated with hypothermia
- Open Access
- 13 June 2026
- Published by Elsevier in SSRN Electronic Journal
Multi-Omics Integration and Machine Learning Identify Therapeutic Targets and Candidate Drugs for Hypothermia
Background: Hypothermia is a life-threatening condition lacking specific pharmacological treatments. This study aims to identify therapeutic targets and repurposable drugs using multi-omics data.Methods: Initially, 2,532 druggable genes were curated from the Drug-Gene Interaction Database and established literature. These were cross-referenced with cis-eQTL and cis-pQTL datasets, encompassing 870,655 and 114,281 SNPs for blood, respectively, alongside 2,379 shared SNPs across adipose, skeletal muscle, and heart tissues. Matched instrumental variables were integrated with hypothermia GWAS summary statistics for two-sample Mendelian randomization (MR) and Bayesian colocalization. Candidate targets were cross-validated through a Random Forest (RF) algorithm and transcriptomic differential expression analysis (DEA). Drug repurposing was evaluated using DrugBank.Results: MR analysis identified 36 druggable genes causally associated with hypothermia. Bayesian colocalization strongly supported four core targets (PP.H4 > 0.900): COL18A1, SLC1A7, ADIPOQ, and MERTK. The RF model (AUC = 0.865) successfully validated ADIPOQ as a shared predictive gene. Transcriptomic analysis revealed significant alterations in SLC1A3 and SLCO4A1, providing family-level corroboration for SLC1A7 under cold exposure. Drug repurposing identified Ningetinib (MERTK inhibitor) and Ocriplasmin (COL18A1 degrader) as promising candidates.Conclusions: Multi-omics and machine learning highlight COL18A1, SLC1A7, ADIPOQ, and MERTK as reliable therapeutic targets. Ningetinib and Ocriplasmin represent promising repurposable drugs for hypothermia management.
- 13 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMulti-Omics Integration and Machine Learning Identify Therapeutic Targets and Candidate Drugs for Hypothermia
Background: Hypothermia is a life-threatening condition lacking specific pharmacological treatments. This study aims to identify therapeutic targets and repurposable drugs using multi-omics data.Methods: Initially, 2,532 druggable genes were curated from the Drug-Gene Interaction Database and established literature. These were cross-referenced with cis-eQTL and cis-pQTL datasets, encompassing 870,655 and 114,281 SNPs for blood, respectively, alongside 2,379 shared SNPs across adipose, skeletal muscle, and heart tissues. Matched instrumental variables were integrated with hypothermia GWAS summary statistics for two-sample Mendelian randomization (MR) and Bayesian colocalization. Candidate targets were cross-validated through a Random Forest (RF) algorithm and transcriptomic differential expression analysis (DEA). Drug repurposing was evaluated using DrugBank.Results: MR analysis identified 36 druggable genes causally associated with hypothermia. Bayesian colocalization strongly supported four core targets (PP.H4 > 0.900): COL18A1, SLC1A7, ADIPOQ, and MERTK. The RF model (AUC = 0.865) successfully validated ADIPOQ as a shared predictive gene. Transcriptomic analysis revealed significant alterations in SLC1A3 and SLCO4A1, providing family-level corroboration for SLC1A7 under cold exposure. Drug repurposing identified Ningetinib (MERTK inhibitor) and Ocriplasmin (COL18A1 degrader) as promising candidates.Conclusions: Multi-omics and machine learning highlight COL18A1, SLC1A7, ADIPOQ, and MERTK as reliable therapeutic targets. Ningetinib and Ocriplasmin represent promising repurposable drugs for hypothermia management.
- 11 May 2026
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 80 (8) , 814-832
Identification of PTPRR gene associated with cirrhosis and sarcopenia based on bioinformatics and machine learning
Cirrhosis and sarcopenia frequently coexist and are associated with poor clinical outcomes; however, their shared genetic basis remains incompletely understood. We applied conditional and conjunctional false discovery rate (cFDR/ccFDR) analyses to genome-wide association study (GWAS) summary statistics for cirrhosis and sarcopenia-related traits, including appendicular lean mass (ALM) and usual walking pace (UWP). In parallel, weighted gene co-expression network analysis (WGCNA) and three machine learning algorithms (LASSO, random forest, and support vector machine-recursive feature elimination) were applied to liver and skeletal muscle transcriptomes. External validation was performed using independent transcriptomic cohorts. Two-sample Mendelian randomization (MR) was conducted to explore causal directions. GWAS-based pleiotropic analysis identified seven shared genetic loci for both conditions cirrhosis and sarcopenia. Transcriptomic and machine learning analyses prioritized eight shared candidate genes across liver and skeletal muscle tissues, among which PTPRR emerged as a convergent candidate identified by multiple analytical layers. Functional enrichment revealed pleiotropic loci were primarily associated with lipid metabolism and inflammatory pathways, whereas machine learning-derived genes were enriched in intracellular signaling and transcriptional regulation. MR analyses further suggested that genetically predicted higher ALM and faster UWP were associated with a lower risk of cirrhosis (inverse-variance weighted [IVW] P = 0.0127 and 0.0211, respectively). By jointly reporting pleiotropic genetic loci and shared candidate genes, this study provides a multi-layered view of the genetic architecture underlying cirrhosis-sarcopenia comorbidity and supports the robustness of the identified gene signature across independent transcriptomic datasets, highlighting candidate molecular targets for future mechanistic investigation.
- 11 May 2026
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 80 (8) , 814-832
Identification of PTPRR gene associated with cirrhosis and sarcopenia based on bioinformatics and machine learning
Cirrhosis and sarcopenia frequently coexist and are associated with poor clinical outcomes; however, their shared genetic basis remains incompletely understood. We applied conditional and conjunctional false discovery rate (cFDR/ccFDR) analyses to genome-wide association study (GWAS) summary statistics for cirrhosis and sarcopenia-related traits, including appendicular lean mass (ALM) and usual walking pace (UWP). In parallel, weighted gene co-expression network analysis (WGCNA) and three machine learning algorithms (LASSO, random forest, and support vector machine-recursive feature elimination) were applied to liver and skeletal muscle transcriptomes. External validation was performed using independent transcriptomic cohorts. Two-sample Mendelian randomization (MR) was conducted to explore causal directions. GWAS-based pleiotropic analysis identified seven shared genetic loci for both conditions cirrhosis and sarcopenia. Transcriptomic and machine learning analyses prioritized eight shared candidate genes across liver and skeletal muscle tissues, among which PTPRR emerged as a convergent candidate identified by multiple analytical layers. Functional enrichment revealed pleiotropic loci were primarily associated with lipid metabolism and inflammatory pathways, whereas machine learning-derived genes were enriched in intracellular signaling and transcriptional regulation. MR analyses further suggested that genetically predicted higher ALM and faster UWP were associated with a lower risk of cirrhosis (inverse-variance weighted [IVW] P = 0.0127 and 0.0211, respectively). By jointly reporting pleiotropic genetic loci and shared candidate genes, this study provides a multi-layered view of the genetic architecture underlying cirrhosis-sarcopenia comorbidity and supports the robustness of the identified gene signature across independent transcriptomic datasets, highlighting candidate molecular targets for future mechanistic investigation.
- 1 September 2025
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 15 (3) , 163-177
Visual Impairment and Handgrip Strength in Aging: Evidence from Bidirectional Mendelian Randomization
Observational studies link handgrip strength (HGS, a key sarcopenia sign) and visual impairment (VI), but their causality is unknown. We used bidirectional Mendelian Randomization (MR)—a genetic method to test causality—to explore if VI affects HGS, and if body mass index (BMI) plays a role. We used genetic data from large groups: FinnGen (218 792 people, VI), UK Biobank (461 089 people, HGS), and EBI/MRC-IEU (532 396 people, BMI). We focused on age-related VI (cataract, glaucoma, high eye pressure), used genetic markers linked to these traits to test causality, and did additional MR to check VI’s direct effect on HGS and BMI’s potential role as a middle factor. MR showed more severe VI tied to lower HGS: genetic predisposition to cataract reduced normal HGS chance by 48% (OR = 0.52, 95% CI 0.28–0.97, P = 0.04); genetic glaucoma susceptibility linked to a small but reliable HGS reduction (OR = 0.99, 95% CI 0.991–0.998, P < 0.001)—small per person but meaningful for older adults due to glaucoma’s high prevalence. Further analyses confirmed glaucoma’s direct harm to HGS. BMI had a weak mediating role: it explained 11% of cataract’s effect and 44% of glaucoma’s effect, but its actual impact was very small. These confirm age-related VI is a modifiable risk factor for older adults’ functional decline. Age-related VI—especially cataract and glaucoma—causes lower HGS. Vision assessment should be part of geriatric care to prevent sarcopenia and frailty, key to older adults’ health.
- 1 September 2025
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 15 (3) , 163-177
Visual Impairment and Handgrip Strength in Aging: Evidence from Bidirectional Mendelian Randomization
Observational studies link handgrip strength (HGS, a key sarcopenia sign) and visual impairment (VI), but their causality is unknown. We used bidirectional Mendelian Randomization (MR)—a genetic method to test causality—to explore if VI affects HGS, and if body mass index (BMI) plays a role. We used genetic data from large groups: FinnGen (218 792 people, VI), UK Biobank (461 089 people, HGS), and EBI/MRC-IEU (532 396 people, BMI). We focused on age-related VI (cataract, glaucoma, high eye pressure), used genetic markers linked to these traits to test causality, and did additional MR to check VI’s direct effect on HGS and BMI’s potential role as a middle factor. MR showed more severe VI tied to lower HGS: genetic predisposition to cataract reduced normal HGS chance by 48% (OR = 0.52, 95% CI 0.28–0.97, P = 0.04); genetic glaucoma susceptibility linked to a small but reliable HGS reduction (OR = 0.99, 95% CI 0.991–0.998, P < 0.001)—small per person but meaningful for older adults due to glaucoma’s high prevalence. Further analyses confirmed glaucoma’s direct harm to HGS. BMI had a weak mediating role: it explained 11% of cataract’s effect and 44% of glaucoma’s effect, but its actual impact was very small. These confirm age-related VI is a modifiable risk factor for older adults’ functional decline. Age-related VI—especially cataract and glaucoma—causes lower HGS. Vision assessment should be part of geriatric care to prevent sarcopenia and frailty, key to older adults’ health.
- Open Access
- 30 August 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 303, 118966
Comment on “Ambient air pollution exposure and the risk of probable sarcopenia: A prospective cohort study”
- 30 August 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 303, 118966
Open AccessComment on “Ambient air pollution exposure and the risk of probable sarcopenia: A prospective cohort study”
- 12 June 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 245, 108209
Comment on “Long-term air pollution exposure and risk of SARS-CoV-2 infection: A UK-wide cohort study”
- 12 June 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 245, 108209
Comment on “Long-term air pollution exposure and risk of SARS-CoV-2 infection: A UK-wide cohort study”
- 15 January 2025
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 131, 105762
Identifying semaphorin 3C as a biomarker for sarcopenia and coronary artery disease via bioinformatics and machine learning
- 15 January 2025
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 131, 105762
Identifying semaphorin 3C as a biomarker for sarcopenia and coronary artery disease via bioinformatics and machine learning
- 3 January 2025
- Published by Springer Nature in Calcified Tissue International
- Vol. 116 (1) , 1-11
Multi-trait Genome-Wide Analysis Identified 20 Novel Loci for Sarcopenia-Related Traits in UK Biobank
This study aims to identify novel loci associated with sarcopenia-related traits in UK Biobank (UKB) through multi-trait genome-wide analysis. To identify novel loci associated with sarcopenia, we integrated the genome-wide association studies (GWAS) of usual walking pace (UWP) and hand grip strength (HGS) to conduct a joint association study known as multi-trait analysis of GWAS (MTAG). We performed a transcriptome-wide association study (TWAS) to analyze the results of MTAG in relation to mRNA expression data for genes identified in skeletal muscle. Additionally, we utilized Weighted Gene Co-Expression Network Analysis (WGCNA) and Protein–Protein Interaction (PPI) networks to explore the relationships between the identified genes and hub genes related to sarcopenia. We identified 15 novel loci associated with UWP and 5 novel loci associated with HGS at the genome wide significance level (GWS, \(p<5\times {10}^{-8}\)). After TWAS (\({p}_{TWAS}<6.659\times {10}^{-6}, 0.05/7509\)), we found two significant genes: PPP1R3A, located at 7q31.1 and associated with HGS, and ZBTB38, located at 3q23 and associated with UWP. 11 identified genes associated with hub genes for sarcopenia were obtained through WGCNA. Our findings offer new insights into biological mechanisms underlying sarcopenia and identify several novel genes related to sarcopenia that warrant in-depth study. Graphical abstract- 3 January 2025
- Published by Springer Nature in Calcified Tissue International
- Vol. 116 (1) , 1-11
Multi-trait Genome-Wide Analysis Identified 20 Novel Loci for Sarcopenia-Related Traits in UK Biobank
This study aims to identify novel loci associated with sarcopenia-related traits in UK Biobank (UKB) through multi-trait genome-wide analysis. To identify novel loci associated with sarcopenia, we integrated the genome-wide association studies (GWAS) of usual walking pace (UWP) and hand grip strength (HGS) to conduct a joint association study known as multi-trait analysis of GWAS (MTAG). We performed a transcriptome-wide association study (TWAS) to analyze the results of MTAG in relation to mRNA expression data for genes identified in skeletal muscle. Additionally, we utilized Weighted Gene Co-Expression Network Analysis (WGCNA) and Protein–Protein Interaction (PPI) networks to explore the relationships between the identified genes and hub genes related to sarcopenia. We identified 15 novel loci associated with UWP and 5 novel loci associated with HGS at the genome wide significance level (GWS, \(p<5\times {10}^{-8}\)). After TWAS (\({p}_{TWAS}<6.659\times {10}^{-6}, 0.05/7509\)), we found two significant genes: PPP1R3A, located at 7q31.1 and associated with HGS, and ZBTB38, located at 3q23 and associated with UWP. 11 identified genes associated with hub genes for sarcopenia were obtained through WGCNA. Our findings offer new insights into biological mechanisms underlying sarcopenia and identify several novel genes related to sarcopenia that warrant in-depth study. Graphical abstract- 20 January 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 350, 822-823
Causal relationship between sleep duration and depression: A bi-directional two-sample Mendelian randomization study
- 20 January 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 350, 822-823
Causal relationship between sleep duration and depression: A bi-directional two-sample Mendelian randomization study
- Open Access
- 12 October 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (1) , 741-742
A Mendelian randomization study of Alzheimer's disease and daytime napping
- 12 October 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (1) , 741-742
Open AccessA Mendelian randomization study of Alzheimer's disease and daytime napping